Medicus Pharma Ltd. Announces First Patient Randomized in Phase 2 Trial of SKNJCT-003 for the Treatment of Nodular Basal Cell Carcinoma in Adults

Yahoo FinanceAug 27 20:36

Medicus Pharma Ltd.: Files for IPO, Intends to Apply to List Common Shares and Warrants on a U.S. Exchange Under Symbols 'MDCX' and 'MDCXW,' Respectively

Dow JonesJul 16 05:59

Medicus Pharma Ltd.: Common Shares Are Listed in Canada on the TSX Venture Exchange Under 'MDCX'

Dow JonesJul 16 05:59

Medicus Pharma Ltd. Submits Updated Phase 2 Clinical Protocol to Non-Invasively Treat Basal Cell Carcinoma of the Skin

newsfileJul 15 19:30

Medicus Pharma Ltd. Announces Closing of Non-Brokered Private Placement of Common Shares and Conversion of Convertible Notes

newsfileJul 5 19:30

Medicus Pharma Ltd. Announces Proposed Non-Brokered Private Placement of Common Shares and Conversion of Convertible Notes

newsfileJun 27 06:00